TickerFacts.

Petros Pharmaceuticals, Inc. (PTPI): R&D Expense

Annual figures by period end, from SEC filings.

$2.62M
Year ended 2024-12-31
+13.5%
3-year compound annual growth
2020-12-31: $459.6K2021-12-31: $1.79M2022-12-31: $1.74M2023-12-31: $2.41M2024-12-31: $2.62M$2.62M
2020-12-31 R&D Expense (USD) 2024-12-31
Period endedR&D ExpenseChange YoYSource filing
2024-12-31$2.62M+8.5%2025-03-31, From 2024-01-01
2023-12-31$2.41M+38.4%2025-03-31, From 2023-01-01
2022-12-31$1.74M-2.7%2024-04-01, From 2022-01-01
2021-12-31$1.79M+289.1%2023-03-31, From 2021-01-01
2020-12-31$459.6Kn/a2022-03-31, From 2020-01-01